Newstral
Article
bizjournals.com on 2018-12-27 19:26
FDA approves Teva's digital inhaler for asthma & COPD patients
Related news
- FDA approves return of popular Primatene Mist asthma inhalerjournalrecord.com
- FDA OKs 1st generic version of popular Advair asthma inhalerSeattle Times
- HFDA Approves Return of Popular Primatene Mist Asthma Inhalerhamodia.com
- FDA approves the return of popular Primatene Mist asthma inhalerstaradvertiser.com
- FDA Committee Recommends Approval of Teva's Asthma DrugHaaretz
- FDA approves app-connected digital inhalerengadget
- FDA Approves Teva's Generic Version of Mylan's EpiPenHaaretz
- FDA Approves Teva's Generic Version of EpiPen Injectorwsj.com
- FDA approves Regeneron asthma drugbizjournals.com
- FDA approves Boehringer’s asthma treatmentwestfaironline.com
- FDA OKs Glaxo’s inhaler, first one to combine 3 medicinesseattletimes.com
- FDA panel backs Glaxo inhaler for adults onlyThe Salt Lake Tribune
- FDA OKs Glaxo's Inhaler, First One to Combine 3 Medicinesmemphisdailynews.com
- FDA OKs Glaxo's inhaler, first one to combine 3 medicinesChicago Tribune
- Expanding Impact for Patients with Asthma and COPDhuffingtonpost.com